Comparison of blood dopamine in Parkinson's patients treated with levodopa carbidopa entacapone vs levodopa benserazide: A randomized controlled trial - PubMed
3 hours ago
- #Parkinson's disease
- #Levodopa therapy
- #Randomized controlled trial
- The study compares two levodopa-based treatments (LCE vs. LB) for Parkinson's disease.
- Both treatments increased plasma dopamine levels in early-stage, unilateral Parkinson's patients.
- No significant difference in dopamine elevation was found between LCE and LB within 180 minutes.
- The research suggests further large-scale studies are needed to assess long-term outcomes.
- The trial was a prospective, single-center, randomized controlled study with 90 participants.